St John's wort (Hypericum perforatum) modulates evoked potentials in guinea pig hippocampal slices via AMPA and GABA receptors

By Langosch J.M.   Zhou X.-Y.   Heinen M.   Kupferschmid S.   Chatterjee S.S.   Noldner M.   Walden J.  

European Neuropsychopharmacology, Vol. 12, Iss. 3, 2002-06 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Sub-chronic treatment with an extract of Hypericum perforatum (St John's wort) significantly reduces cortisol and corticosterone in the rat brain

By Franklin M.   Reed A.   Murck H.  

European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. : 7-10

Elsevier

Access to resources Recommend Favorite

The Efficacy of Hypericum perforatum (St John's Wort) for the Treatment of Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

By Canning Sarah  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 207-225

Adis International

Access to resources Recommend Favorite

Main Active Components of St. John's Wort (Hypericum Perforatum) Extracts: Current Analytical Procedures for Pharmacokinetics and Concentration-Response Studies

By  

Current Pharmaceutical Analysis, Vol. 2, Iss. 1, 2006-01 ,pp. : 59-68

Bentham Science Publishers

Access to resources Recommend Favorite

Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines

By Hostanska K.   Reichling J.   Bommer S.   Weber M.   Saller R.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 56, Iss. 1, 2003-07 ,pp. : 121-132

Elsevier

Access to resources Recommend Favorite